Genetic Disorders of Glomerular Basement Membranes

This review provides current information about glomerular disorders that arise directly from inherited abnormalities in extracellular matrix proteins intrinsic to the glomerular basement membrane (Alport syndrome, thin basement membrane nephropathy, HANAC syndrome and Pierson syndrome). The authors also discuss disorders involving genetic defects in cellular proteins that result in structural defects in glomerular basement membranes (MYH9-related disorders, nail-patella syndrome).

[1]  H. Kanegane,et al.  Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease. , 2010, Kidney international.

[2]  A. Pastore,et al.  MYH9 related disease: four novel mutations of the tail domain of myosin‐9 correlating with a mild clinical phenotype , 2010, European journal of haematology.

[3]  Dan-hua Zhao,et al.  The first Chinese Pierson syndrome with novel mutations in LAMB2. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  P. Avner,et al.  X-inactivation modifies disease severity in female carriers of murine X-linked Alport syndrome. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[5]  D. Witte,et al.  Thrombocytopenia and proteinuria: question , 2009, Pediatric Nephrology.

[6]  J. Matthews,et al.  Competition between LIM-binding domains. , 2008, Biochemical Society transactions.

[7]  D. Reich,et al.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans , 2008, Nature Genetics.

[8]  Dorothy A. Thompson,et al.  Ophthalmological aspects of Pierson syndrome. , 2008, American journal of ophthalmology.

[9]  D. Vlahov,et al.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis , 2008, Nature Genetics.

[10]  K. Lemley.  Kidney disease in nail–patella syndrome , 2008, Pediatric Nephrology.

[11]  J. Anderson,et al.  Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome , 2008, Journal of Medical Genetics.

[12]  P. Noris,et al.  Position of nonmuscle myosin heavy chain IIA (NMMHC‐IIA) mutations predicts the natural history of MYH9‐related disease , 2008, Human mutation.

[13]  K. Moon,et al.  Variable phenotype of Pierson syndrome , 2008, Pediatric Nephrology.

[14]  R. Witzgall.  How are podocytes affected in nail–patella syndrome? , 2008, Pediatric Nephrology.

[15]  C. Vlangos,et al.  A milder variant of Pierson syndrome , 2008, Pediatric Nephrology.

[16]  T. Desmettre,et al.  COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps. , 2007, The New England journal of medicine.

[17]  Bethan E. Hoskins,et al.  Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. , 2006, Kidney international.

[18]  D. Witte,et al.  Pierson Syndrome: A Novel Cause of Congenital Nephrotic Syndrome , 2006, Pediatrics.

[19]  A. Shaw,et al.  Proteinuria precedes podocyte abnormalities inLamb2-/- mice, implicating the glomerular basement membrane as an albumin barrier. , 2006, The Journal of clinical investigation.

[20]  J. Cruysberg,et al.  Genotype–phenotype studies in nail-patella syndrome show that LMX1B mutation location is involved in the risk of developing nephropathy , 2005, European Journal of Human Genetics.

[21]  J. Savige,et al.  The genetics of thin basement membrane nephropathy. , 2005, Seminars in nephrology.

[22]  T. Aigner,et al.  Human laminin beta2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. , 2004, Human molecular genetics.

[23]  J. Dötsch,et al.  Congenital nephrosis, mesangial sclerosis, and distinct eye abnormalities with microcoria: An autosomal recessive syndrome , 2004, American journal of medical genetics. Part A.

[24]  A. Savoia,et al.  Correlation between the clinical phenotype of MYH9-related disease and tissue distribution of class II nonmuscle myosin heavy chains. , 2004, Genomics.

[25]  D. Barker,et al.  Deletion mapping in Alport syndrome and Alport syndrome‐diffuse leiomyomatosis reveals potential mechanisms of visceral smooth muscle overgrowth , 2003, Human mutation.

[26]  H. Smeets,et al.  X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. , 2003, Journal of the American Society of Nephrology : JASN.

[27]  E. Bongers,et al.  In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys. , 2003, The American journal of pathology.

[28]  R. Ravazzolo,et al.  MYH9-Related Disease: May-Hegglin Anomaly, Sebastian Syndrome, Fechtner Syndrome, and Epstein Syndrome Are not Distinct Entities but Represent a Variable Expression of a Single Illness , 2003, Medicine.

[29]  A. Green,et al.  Nail patella syndrome: a review of the phenotype aided by developmental biology , 2003, Journal of medical genetics.

[30]  P. S. St. John,et al.  Laminin-1 reexpression in Alport mouse glomerular basement membranes1 , 2003 .

[31]  E. Bongers,et al.  Nail-patella syndrome. Overview on clinical and molecular findings , 2002, Pediatric Nephrology.

[32]  H. Saito,et al.  Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions , 2001, Journal of Human Genetics.

[33]  J. Hamlington,et al.  Twenty‐two novel LMX1B mutations identified in nail patella syndrome (NPS) patients , 2001, Human mutation.

[34]  J. White,et al.  Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes. , 2001, American journal of human genetics.

[35]  P. Thorner,et al.  Abnormal glomerular basement membrane laminins in murine, canine, and human Alport syndrome: aberrant laminin alpha2 deposition is species independent. , 2001, Journal of the American Society of Nephrology : JASN.

[36]  M. Kelley,et al.  Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in nonmuscle myosin MYH9. , 2000, American journal of human genetics.

[37]  H. Smeets,et al.  X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. , 2000, Journal of the American Society of Nephrology : JASN.

[38]  M. Moxey-Mims,et al.  End-stage renal disease in two pediatric patients with Fechtner syndrome , 1999, Pediatric Nephrology.

[39]  F. Vitelli,et al.  Identification and characterization of a highly conserved protein absent in the Alport syndrome (A), mental retardation (M), midface hypoplasia (M), and elliptocytosis (E) contiguous gene deletion syndrome (AMME). , 1999, Genomics.

[40]  A. Baldini,et al.  Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome , 1998, Nature Genetics.

[41]  Y. Sado,et al.  Normal distribution of collagen IV in renal basement membranes in Epstein's syndrome. , 1997, Journal of clinical pathology.

[42]  R. Kalluri,et al.  Isoform switching of type IV collagen is developmentally arrested in X-linked Alport syndrome leading to increased susceptibility of renal basement membranes to endoproteolysis. , 1997, The Journal of clinical investigation.

[43]  J. Sanes,et al.  The renal glomerulus of mice lacking s–laminin/laminin β2: nephrosis despite molecular compensation by laminin β1 , 1995, Nature Genetics.

[44]  J. Sanes,et al.  Collagen IV alpha 3, alpha 4, and alpha 5 chains in rodent basal laminae: sequence, distribution, association with laminins, and developmental switches , 1994, The Journal of cell biology.

[45]  C. Kashtan,et al.  Distribution of the α1 and α2 chains of collagen IV and of collagens V and VI in Alport syndrome , 1992 .

[46]  R. T. te Slaa,et al.  Genetic counselling in hereditary osteo-onychodysplasia (HOOD, nail-patella syndrome) with nephropathy. , 1988, Journal of medical genetics.

[47]  J. White,et al.  Fechtner syndrome--a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia. , 1985, Blood.

[48]  M. Lifschitz,et al.  Alport's syndrome associated with macrothrombopathic thrombocytopenia. , 1979, American journal of clinical pathology.

[49]  M. Lagarde,et al.  Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. , 1976, The American journal of medicine.

[50]  R. Glassock,et al.  Hereditary nephritis, deafness and abnormal thrombopoiesis. Study of a new kindred. , 1976, The American journal of medicine.

[51]  A. Michael,et al.  Renal disease in nail-patella syndrome: clinical and morphologic studies. , 1972, Kidney international.

[52]  C. Epstein,et al.  Hereditary macrothrombocytopathia, nephritis and deafness. , 1972, The American journal of medicine.

[53]  M. Ben-bassat,et al.  The glomerular basement membrane in the nail-patella syndrome. , 1971, Archives of pathology.

[54]  E. Pozo,et al.  Ultrastructure of the kidney in the nephropathy of the nail--patella syndrome. , 1970, American journal of clinical pathology.

[55]  F. Cuppage,et al.  The Nail-Patella syndrome. Clinical findings and ultrastructural observations in the kidney. , 1967, Archives of internal medicine.

[56]  M. Pierson,et al.  [AN UNUSUAL CONGENITAL AND FAMILIAL CONGENITAL MALFORMATIVE COMBINATION INVOLVING THE EYE AND KIDNEY]. , 1963, Journal de genetique humaine.

[57]  C. Hawkins,et al.  Renal dysplasia in a family with multiple hereditary abnormalities including iliac horns. , 1950, Lancet.

[58]  Mino Ra,et al.  Osseous dysplasia and dystrophy of the nails; review of the literature and report of a case. , 1948 .

[59]  A. Erdős,et al.  Hereditary nephritis, platelet disorders and deafness — Epstein's syndrome , 2004, Pediatric Nephrology.

[60]  R. Ravazzolo,et al.  Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[61]  P. S. St. John,et al.  Laminin-1 reexpression in Alport mouse glomerular basement membranes. , 2003, Kidney international.

[62]  J. Sanes,et al.  Collagen IV tx 3 , c 4 , and ct 5 Chains in Rodent Basal Laminae : Sequence , Distribution , Association with Laminins , and Developmental Switches , 2002 .

[63]  Corinne Antignac,et al.  Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes. , 2002, Journal of the American Society of Nephrology : JASN.

[64]  C. Antignac,et al.  Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region. , 1997, Cytogenetics and cell genetics.

[65]  J. Grünfeld,et al.  Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[66]  S. J. Cashman,et al.  Variability of the antigenicity of the glomerular basement membrane in nail-patella syndrome. , 1989, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[67]  R. Livingstone,et al.  Osseous dysplasia and dystrophy of the nails; review of the literature and report of a case. , 1948, The American journal of roentgenology and radium therapy.

[68]  E. Bongers,et al.  J Am Soc Nephrol 11: 1762–1766, 2000 Nail-Patella Syndrome: Identification of Mutations in the LMX1B Gene , 2022 .